According to Roche's latest financial reports the company's current EPS (TTM) is ยฃ13.20. In 2022 the company made an earnings per share (EPS) of ยฃ13.20 a decrease over its 2021 EPS that were of ยฃ14.09.
Year | EPS | Change |
---|---|---|
2022 | ยฃ13.20 | -6.29% |
2021 | ยฃ14.09 | -5.53% |
2020 | ยฃ14.91 | 16.56% |
2019 | ยฃ12.79 | 30.3% |
2018 | ยฃ9.82 | 20.22% |
2017 | ยฃ8.17 | -5.81% |
2016 | ยฃ8.67 | 4.62% |
2015 | ยฃ8.29 | -5.13% |
2014 | ยฃ8.74 | -25.05% |
2013 | ยฃ11.66 | 21.73% |
2012 | ยฃ9.57 | 3.82% |
2011 | ยฃ9.22 | 8.16% |
2010 | ยฃ8.53 | 23.72% |
2009 | ยฃ6.89 | -12.31% |
2008 | ยฃ7.86 | -0.34% |
2007 | ยฃ7.89 | 32.13% |
2006 | ยฃ5.97 | 42.56% |
2005 | ยฃ4.19 | -22.7% |
2004 | ยฃ5.42 | 132.85% |
2003 | ยฃ2.33 | -154.73% |
2002 | -ยฃ4.25 | -209.09% |
2001 | ยฃ3.89 | -57.25% |
2000 | ยฃ9.11 | 54.06% |
1999 | ยฃ5.91 | 31.24% |
1998 | ยฃ4.51 |